NCT03769987 (REAS) is a clinical trial of observation in Sarcoidosis, sponsored by University of Cincinnati.

Who is sponsoring NCT03769987?

NCT03769987 is sponsored by University of Cincinnati.

What drugs are being tested in NCT03769987?

Interventions in NCT03769987: observation.

What condition does NCT03769987 study?

NCT03769987 studies Sarcoidosis.

Is NCT03769987 still recruiting?

NCT03769987 is currently status unknown. Last updated 10 December 2018.

Last reviewed 2018-12-10 · How we verify

NCT03769987: REAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry for Advanced Sarcodiosis

Status unknown Last updated 10 December 2018

What this trial tests

trial testing observation in Sarcoidosis in 800 participants. Status unknown.

Timeline

1 January 2017

Primary endpoint
31 December 2019

30 June 2020

Quick facts

Lead sponsor	University of Cincinnati
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	800
Start date	1 January 2017
Primary completion	31 December 2019
Estimated completion	30 June 2020
Sites	1 location across United States

Drugs / interventions tested

observation

Conditions studied

Sarcoidosis — all drugs for Sarcoidosis →

Sponsor

University of Cincinnati

Who can join

Adults 15 to 100, any sex, with Sarcoidosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Registry with evaluation and genetic information of patients with advanced sarcoidosis and matched sarcoidosis

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Health-related quality of life in cardiac sarcoidosis: a systematic review.
Quijano-Campos JC, Sekhri N, Thillai M, Sanders J. · · 2023 · cited 4× · PMID 36974155 · DOI 10.1093/ehjopen/oead009

Verify or expand the search:

Other trials of observation

Trials testing the same drug.

NCT06493448 — Prospective Observational Cohort Study · not yet recruiting
NCT06432153 — Tampa Scale of Kinesiophobia for Heart Taiwan Version Validation · not yet recruiting
NCT06491966 — Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis · recruiting
NCT06327165 — Predictability of ANI (Analgesia Nociception Index) for Spinal Hypotension · unknown
NCT06114446 — The Evaluation of the Effectiveness of Nursing Care Education Provided With Immersive Virtual Reality · NA · completed

Other recruiting trials for Sarcoidosis

Currently open trials in the same condition.

NCT07498842 — Corticosteroid Tapering in Sarcoidosis · NA · recruiting
NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07384897 — Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease · NA · recruiting
NCT06636487 — Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD · NA · active not recruiting
NCT06576505 — Immunological Mechanisms in Sarcoidosis · recruiting

Other University of Cincinnati trials

Trials by the same sponsor.

NCT05605366 — Minocycline In Neurocognitive Outcomes - Sickle Cell Disease · Phase 1 · not yet recruiting
NCT07528638 — Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND) · NA · not yet recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07447895 — Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies · NA · not yet recruiting
NCT07231588 — Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03769987 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Cincinnati
Last refreshed: 10 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03769987.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing